Samuel K Campos - Publications

Affiliations: 
2008- Immunobiology University of Arizona, Tucson, AZ 
Area:
Virology
Website:
https://immunobiology.arizona.edu/research/campos-lab

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Uhlorn BL, Jackson R, Li S, Bratton SM, Van Doorslaer K, Campos SK. Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection. Plos Pathogens. 16: e1009028. PMID 33253291 DOI: 10.1371/journal.ppat.1009028  1
2020 Uhlorn BL, Gamez ER, Li S, Campos SK. Attenuation of cGAS/STING activity during mitosis. Life Science Alliance. 3. PMID 32661021 DOI: 10.26508/lsa.201900636  1
2019 Li S, Bronnimann MP, Williams SJ, Campos SK. Glutathione contributes to efficient post-Golgi trafficking of incoming HPV16 genome. Plos One. 14: e0225496. PMID 31743367 DOI: 10.1371/journal.pone.0225496  1
2017 Aydin I, Villalonga-Planells R, Greune L, Bronnimann MP, Calton CM, Becker M, Lai KY, Campos SK, Schmidt MA, Schelhaas M. A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry. Plos Pathogens. 13: e1006308. PMID 28464022 DOI: 10.1371/journal.ppat.1006308  0.6
2017 Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, Williamson TR, Molugu SK, Bernal RA, Campos SK. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis. Plos Pathogens. 13: e1006200. PMID 28463988 DOI: 10.1371/Journal.Ppat.1006200  1
2016 Bronnimann MP, Calton CM, Chiquette SF, Li S, Lu M, Chapman JA, Bratton KN, Schlegel AM, Campos SK. Furin Cleavage of L2 During Papillomavirus Infection: Minimal Dependence on Cyclophilins. Journal of Virology. PMID 27122588 DOI: 10.1128/JVI.00038-16  1
2015 Christakos KJ, Chapman JA, Fane BA, Campos SK. PhiXing-it, displaying foreign peptides on bacteriophage ΦX174. Virology. 488: 242-248. PMID 26655242 DOI: 10.1016/J.Virol.2015.11.021  0.92
2014 Campos SK. New structural model of adenoviral cement proteins is not yet concrete Proceedings of the National Academy of Sciences of the United States of America. 111: E4542-E4543. PMID 25304640 DOI: 10.1073/pnas.1415364111  0.92
2013 Calton CM, Schlegel AM, Chapman JA, Campos SK. Human papillomavirus type 16 does not require cathepsin L or B for infection. The Journal of General Virology. 94: 1865-9. PMID 23677785 DOI: 10.1099/vir.0.053694-0  0.92
2013 Bronnimann MP, Chapman JA, Park CK, Campos SK. A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. Journal of Virology. 87: 464-73. PMID 23097431 DOI: 10.1128/Jvi.01539-12  0.92
2012 Campos SK, Chapman JA, Deymier MJ, Bronnimann MP, Ozbun MA. Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration. Journal of Virology. 86: 4169-81. PMID 22345461 DOI: 10.1128/JVI.05493-11  0.92
2012 Bergant MaruÅ¡ič M, Ozbun MA, Campos SK, Myers MP, Banks L. Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (Copenhagen, Denmark). 13: 455-67. PMID 22151726 DOI: 10.1111/j.1600-0854.2011.01320.x  0.92
2009 Campos SK, Ozbun MA. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes Plos One. 4. DOI: 10.1371/journal.pone.0004463  0.92
2007 Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Current Gene Therapy. 7: 189-204. PMID 17584037 DOI: 10.2174/156652307780859062  0.92
2006 Marsh MP, Campos SK, Baker ML, Chen CY, Chiu W, Barry MA. Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. Journal of Virology. 80: 11881-6. PMID 16987967 DOI: 10.1128/Jvi.01471-06  0.92
2006 Campos SK, Barry MA. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology. 349: 453-62. PMID 16504233 DOI: 10.1016/J.Virol.2006.01.032  0.92
2005 Campos SK, Barry MA. 29. Redirection of Adenoviral Tropism through Capsomers Other Than Fiber Is Generally Inefficient and Dependent on Ligand-Receptor Biology Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.031  0.92
2004 Campos SK, Barry MA. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Human Gene Therapy. 15: 1125-30. PMID 15610612 DOI: 10.1089/Hum.2004.15.1125  0.92
2004 Campos SK, Parrott MB, Barry MA. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 942-54. PMID 15194061 DOI: 10.1016/J.Ymthe.2004.03.006  0.92
2004 Campos SK, Parrott MB, March M, Chiu W, Barry MA. 1017. Metabolically Biotinylated Viruses for Vector Targeting, Virus Purification, and Capsid Imaging Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.962  0.92
2003 Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 688-700. PMID 14529842 DOI: 10.1016/S1525-0016(03)00213-2  0.92
2003 Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB. Biotinylated gene therapy vectors. Expert Opinion On Biological Therapy. 3: 925-40. PMID 12943452 DOI: 10.1517/14712598.3.6.925  0.92
Show low-probability matches.